Share
Market Research Report

CELL AND GENE THERAPY FOR ONCOLOGY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Therapy TypeCell Therapy (Stem Cell Therapy, T-Cell Therapy, Mesenchymal Stem Cell (MSC) Therapy, and Others) and Gene Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Therapy Gene Transfer)
  • By TechnologyCell Therapy Technology (Autologous, Allogeneic, and Xenogeneic) and Gene Therapy Technology (Viral Vector-Based Gene Therapy and Non-Viral Vector-Based Gene Therapy)
  • By IndicationBreast Cancer · Lung Cancer · Prostate Cancer · Leukaemia and Lymphoma · and Others
  • By End UserHospitals and Cancer Treatment Centers · Research and Academic Institutes · Biotechnology and Pharmaceutical Companies · and Others
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East and Africa
  • Published In08 May 2026
  • Report CodeCMI9477
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Cell and Gene Therapy for Oncology Market, By Therapy Type
      • Global Cell and Gene Therapy for Oncology Market, By Technology
      • Global Cell and Gene Therapy for Oncology Market, By Indication
      • Global Cell and Gene Therapy for Oncology Market, By End User
      • Global Cell and Gene Therapy for Oncology Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Market Opportunities
    • Regulatory Scenario
    • Key Developments
    • Industry Trends
  4. Global Cell and Gene Therapy for Oncology Market, By Therapy Type, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Cell Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Stem Cell Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • T-Cell Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Mesenchymal Stem Cell (MSC) Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Gene Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
        • Gene Induced Immunotherapy
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
        • Oncolytic Virotherapy
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
        • Therapy Gene Transfer
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  5. Global Cell and Gene Therapy for Oncology Market, By Technology, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Cell Therapy Technology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Autologous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Allogeneic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Xenogeneic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Gene Therapy Technology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Viral Vector-Based Gene Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Non-Viral Vector-Based Gene Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  6. Global Cell and Gene Therapy for Oncology Market, By Indication, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Breast Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Lung Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Prostate Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Leukaemia and Lymphoma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  7. Global Cell and Gene Therapy for Oncology Market, By End User, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospitals and Cancer Treatment Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Research and Academic Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Biotechnology and Pharmaceutical Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  8. Global Cell and Gene Therapy for Oncology Market, By Region, 2021 - 2033, Value (USD Mn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
        • South Africa
        • North Africa
        • Central Africa
  9. Competitive Landscape

    • Gilead Sciences
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bristol Myers Squibb
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Johnson & Johnson
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Legend Biotech
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • bluebird bio
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • CRISPR Therapeutics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Allogene Therapeutics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Iovance Biotherapeutics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Adaptimmune Therapeutics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  10. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  11. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on ‘Cell and Gene Therapy for Oncology Market' - Global forecast to 2033